Primary buyer interest
Recovery plus gut research
The formula combines three recovery-oriented ingredients with the KPV tripeptide.
COA VerifiedHealing Peptides
Buy Klow Blend 80mg in Canada: BPC-157, TB-500, GHK-Cu and KPV
5.03 reviews
● In stock — ships next business day$110.00
Purchase option
Buy more, save more
2+ vialsSave 5%
5+ vialsSave 10%
10+ vialsSave 15%
Not in stock yet. Leave your email and we will tell you when it is available.
Get notified when it's availableIndependently lab tested — 99%+ purity
COA number printed on every vial
Ships next business day, 1–3 day delivery
Discreet packaging · Interac e-Transfer
Klow Blend is an 80mg multi-peptide formulation studied in metabolic-function, weight-management, and energy-metabolism research. Each vial is lyophilized and independently tested. For research purposes only.
Store lyophilized vials refrigerated and protected from light and moisture. Follow the product-specific storage record after reconstitution.
Orders ship from within Canada in discreet packaging. Express delivery is typically 1–3 business days after dispatch.
Standard returns are not accepted because research materials cannot be safely restocked after delivery. Contact support promptly about damaged, incorrect, or compromised items.
Reconstitution calculator
Turn the vial amount into an easy-to-read volume
Enter three known values. The calculator converts the total vial amount and water added into a concentration, then shows the liquid volume and equivalent U-100 syringe units for the quantity entered.
The calculator does not choose a quantity. It converts the quantity you enter. One milligram equals 1,000 micrograms.
Bacteriostatic water is generally the most appropriate choice for multi-use research preparation because it contains a preservative for repeated vial access.
Concentration40 mg/mL4 mg in each 0.1 mL
Calculated liquid volume0.025 mL2.5 units on a U-100 syringe
Example using the values above: 80mg with 2mL of water equals 40mg/mL. A 1mg quantity equals 0.025mL, or 2.5 U-100 units.
Klow Blend buyer and ingredient guide
Understanding Klow Blend: Recovery, Gut and Inflammation Research
Klow Blend is aimed at buyers who want recovery, connective-tissue, skin, gut, and inflammation-related research in one product. The current label lists BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg, and KPV 10mg, for 80mg total material.
It is essentially the three-component Glow Blend formula with KPV added. KPV is a three-amino-acid fragment of alpha-MSH studied for anti-inflammatory signaling and intestinal models, but the evidence is preclinical and there is no controlled human trial of the complete Klow formula.
Added component
KPV 10mg
KPV has cell and animal evidence involving inflammatory signaling and intestinal models.
Exact formula
10 + 10 + 50 + 10mg
The label identifies all four component amounts for an 80mg total.
Evidence reality
No trial of the blend
Ingredient mechanisms do not establish synergy, safety, or a dependable human result.
Product specifications
- Research name
- Klow Blend
- Compound class
- Four-component peptide research blend
- Listed components
- BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg, and KPV 10mg
- Available strength
- 80mg total blend
- Form
- Lyophilized powder in a vial
- Documentation
- The listing identifies independent testing and COA availability
- Dispatch country
- Canada
- Intended use
- Laboratory and in-vitro research only
Klow Blend ingredient evidence at a glance
The formula combines four separate preclinical research areas, but the complete blend has not been clinically validated.
| Ingredient | Main research interest | Evidence maturity | Buyer takeaway |
|---|---|---|---|
| BPC-157 10mg | Soft tissue, vascular, and gut models | Predominantly animal evidence | Experimental recovery component |
| TB-500 10mg | Actin, cell migration, and wound response | Mostly thymosin beta-4 background evidence | Exact fragment identity matters |
| GHK-Cu 50mg | Collagen, fibroblasts, and extracellular matrix | Mostly cell, animal, and formulation research | Main skin and matrix component |
| KPV 10mg | Inflammatory signaling and intestinal models | Cell and mouse evidence | No proven human gut outcome |
| Complete Klow Blend | Combined recovery and gut concept | No robust controlled human trial | No established synergy or result timeline |
A multi-component COA should be read component by component. One aggregate purity figure may not establish the identity or amount of every ingredient.
What is in Klow Blend and what is each part for?
BPC-157 10mg and TB-500 10mg supply the recovery-oriented part of the formula, with preclinical literature involving soft tissue, vascular response, actin, and cell migration. GHK-Cu 50mg is the largest component and adds copper-peptide research involving collagen, fibroblasts, extracellular matrix, and wound models.
KPV 10mg distinguishes Klow from Glow Blend. KPV is the Lys-Pro-Val tripeptide at the end of alpha-MSH. Cell and mouse studies report effects on NF-kappaB, MAP kinase, inflammatory cytokines, and experimental colitis, but there are no robust human trials showing that KPV treats gut or inflammatory conditions.
Who is Klow Blend best suited to?
Klow is the most complete recovery blend in the current catalog for someone intentionally looking for BPC-157, TB-500, GHK-Cu, and KPV together. It is more convenient than four separate purchases and the label states each component amount.
That convenience comes with less control. Standalone compounds are easier to evaluate when one pathway is the real priority, when independent COAs matter, or when a buyer wants to avoid paying for ingredients they did not specifically choose.
Klow Blend compared with Glow Blend
KPV is the only ingredient difference shown on the current labels.
| Product | Shared formula | Additional ingredient | Total |
|---|---|---|---|
| Glow Blend | BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg | None | 70mg |
| Klow Blend | BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg | KPV 10mg | 80mg |
Choose Klow only when KPV is an intentional part of the research question. More ingredients do not automatically mean a better outcome.
Klow Blend versus Glow Blend
Both products list BPC-157 10mg, TB-500 10mg, and GHK-Cu 50mg. Klow adds KPV 10mg, bringing the total from 70mg to 80mg. That is the full product difference shown on the labels.
Choose Glow when the skin, collagen, and recovery trio is the intended formula. Choose Klow when you also want the KPV anti-inflammatory and intestinal-research rationale. The extra ingredient does not make Klow universally stronger or better.
How to read the 80mg Klow Blend formula
The 80mg total is the sum of BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg, and KPV 10mg. It does not mean 80mg of each ingredient and the blend is not divided equally.
Choose Klow when all four labelled components are intentional and a precombined formula is more useful than independent control. If KPV is not part of the goal, Glow Blend contains the same other three amounts in a 70mg vial.
How to evaluate Klow Blend quality before buying
The listing identifies independent testing and COA availability. Before ordering, confirm that the available certificate identifies the compound or blend, batch or lot, test date, analytical method, and reported result. After delivery, compare the vial label with that exact documentation rather than relying on a generic certificate.
Identity, purity, fill quantity, sterility, and endotoxin testing answer different questions. A large purity percentage does not prove every other quality attribute, so buyers should check which tests are actually reported and avoid assuming that an unlisted result was performed.
Research-use and approval status
The Bison Peptides Klow Blend vial is supplied as a technical laboratory research material, not an authorized prescription formulation. The page summarizes published research to help buyers understand the compound, evidence, and product format; it is not an individual treatment or dosing recommendation.
Related research pages
Primary sources and status references
- PubMed: KPV uptake and intestinal inflammation research
- PubMed: KPV in murine inflammatory-bowel models
- PubMed: BPC-157 musculoskeletal soft-tissue research
- PubMed: GHK-Cu and extracellular-matrix remodeling
- Health Canada: Warning about unauthorized peptide products
Content reviewed August 11, 2026 by the Bison Peptides editorial team.
Reviews
5.03 reviews
Nice all-in-one option
“I was comparing the different blends and ended up choosing Klow because I liked everything being combined in one vial. The 80mg product arrived exactly as described, securely packaged and clearly labeled. Overall I'm very happy with how simple the entire order was.”
80mg ·
Jennifer P. · Verified buyer
Excellent presentation
“The first thing I noticed was how professional the packaging looked compared with some other sites I've ordered from. The Klow Blend vial was well protected and the label made the contents easy to identify. Shipping and checkout were both straightforward too.”
80mg ·
Lauren C. · Verified buyer
Glad I tried the Klow Blend
“This was my first time ordering a blend rather than purchasing everything separately. I liked the convenience and the order showed up exactly as expected. The vial was sealed, clean, and professionally labeled. I'll likely stick with this format for future purchases.”
80mg ·
Megan S. · Verified buyer
Frequently asked questions
What is in Klow Blend 80mg?
The current label lists BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg, and KPV 10mg. Together they total 80mg.
What is Klow Blend commonly researched for?
Buyers commonly compare it for broad recovery, connective-tissue, skin, gut, and inflammation-related research. Those themes come from the individual ingredient literature, not from a clinical trial of the complete blend.
What does KPV add to Klow Blend?
KPV adds a preclinical anti-inflammatory and intestinal-research rationale. Cell and mouse studies report effects on inflammatory signaling and experimental colitis, but controlled human benefit has not been established.
What is the difference between Klow and Glow Blend?
Both contain BPC-157 10mg, TB-500 10mg, and GHK-Cu 50mg. Klow adds KPV 10mg, so its total is 80mg instead of 70mg.
Is Klow Blend better than buying separate peptides?
It is more convenient when all four ingredients are intentional. Separate vials provide clearer identity, independent COAs, and more control over which compound is being evaluated.
Does the 80mg total mean equal amounts?
No. The components are not equal: GHK-Cu is 50mg, while BPC-157, TB-500, and KPV are 10mg each.
Does Klow Blend have human clinical evidence?
No robust controlled human trial has evaluated this exact four-component formula. Most ingredient evidence is preclinical, and a result for one component cannot establish the performance of the blend.
What should a Klow Blend COA show?
Ideally it should identify all four components, the batch or lot, test date, analytical method, and component-specific identity or quantity results. One total purity percentage may not fully characterize the blend.
